Biotech

All Articles

Basilea credit ratings $268M BARDA backing for antifungals, antibiotics

.Basilea Pharmaceutica's work building new antifungals has actually gotten a substantial improvement...

Capricor offers Europe liberties to late-stage DMD treatment for $35M

.Having actually scooped up the U.S. civil rights to Capricor Rehabs' late-stage Duchenne muscle dys...

FDA fragments adcomm for Applied's unusual condition medicine

.After dismissing the choice meeting for Applied Therapeutics' metabolic condition drug govorestat, ...

Novo inks $600M NanoVation offer to examine hereditary medications ex-liver

.Novo Nordisk is actually proceeding its own press into hereditary medications, consenting to pay Na...

Innovent links cytokine to intestines cancer cells actions

.Innovent Biologics has actually made the instance that its gate inhibitor-cytokine blend healthy pr...

Merck, Daiichi ADC attacks target in phase 3 bronchi cancer cells study

.A phase 3 trial of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate...

Rakovina deepens AI concentrate with collab to select cancer cells targets

.5 months after Rakovina Therapeutics turned towards artificial intelligence, the cancer-focused bio...

Ascendis' dwarfism medication smash hits in period 3, endangers BioMarin

.Ascendis Pharma has actually become a prospective danger to BioMarin's Voxzogo, mentioning phase 3 ...

Despite ph. 3 skip, Alkeus finds road in advance for eye health condition possession

.Though Alkeus Pharmaceuticals' oral eye illness asset stopped working to substantially minimize geo...

Kairos goes social with $6M IPO to finance trials of cancer medicine

.With a triad of biotechs reaching the Nasdaq on Friday, it was very easy to miss out on a smaller-s...